🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hiroshi Matsui

Kansai Medical University

ORCID: 0000-0002-7402-0755

Also affiliated with Gunma University, Osaka University of Human Sciences

Biochemistry, Genetics and Molecular BiologyMaterials ScienceEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Iron oxide and various metal oxide nanotubes engineered by one-pot double galvanic replacement based on reduction potential hierarchy of metal templates and ion precursors”.

Iron oxide and various metal oxide nanotubes engineered by one-pot double galvanic replacement based on reduction potential hierarchy of metal templates and ion precursors

RSC Advances(2020)10.1039/d0ra07482a
N/A
0DataRank · unranked
2 citations

Steven Medvedovsky, Justin Fang, Timothy Lau, Hiroshi Matsui, Aloka Paragodaarachchi

Magnetically Induced Brownian Motion of Iron Oxide Nanocages in Alternating Magnetic Fields and Their Application for Efficient siRNA Delivery

Nano Letters(2022)10.1021/acs.nanolett.2c02691
N/A
0DataRank · unranked
28 citations

Justin Fang, Aloka Paragodaarachchi, Keita Kodama, Daniela Yakobashvili, Yuko Ichiyanagi +2 more

Delivery of mGluR5 siRNAs by Iron Oxide Nanocages by Alternating Magnetic Fields for Blocking Proliferation of Metastatic Osteosarcoma Cells

International Journal of Molecular Sciences(2022)10.3390/ijms23147944
N/A
0DataRank · unranked
6 citations

Pooja Prakash Rao, Hiroshi Matsui, Shahana S. Mahajan, Min A Kang

Nanocage-incorporated engineered destabilized 3'UTR ARE of ERBB2 inhibits tumor growth and liver and lung metastasis in EGFR T790M osimertinib- and trastuzumab-resistant and ERBB2-expressing NSCLC via the reduction of ERBB2

Frontiers in Oncology(2024)10.3389/fonc.2024.1344852
N/A
0DataRank · unranked
0 citations

Joo Sun Mun, Aloka Paragodaarachchi, Baris Boylu, M. A. Nzegwu, Hiroshi Matsui +2 more